Distinct effects of different doses of kaempferol on D-GalN/LPS-induced ALF depend on the autophagy pathway

被引:11
|
作者
Tian, Yuan [1 ]
Ren, Feng [1 ]
Xu, Ling [1 ]
Zhang, Xiangying [1 ]
机构
[1] Capital Med Univ, Beijing Youan Hosp, Beijing Inst Hepatol, 8 Xitoutiao Rd,Youwai St, Beijing 100069, Peoples R China
基金
中国国家自然科学基金;
关键词
kaempferol; acute liver failure; autophagy; liver inflammation; D-galactosamine; lipopolysaccharide; D-GALACTOSAMINE/LIPOPOLYSACCHARIDE; MOUSE-LIVER; MICE; FAILURE; MODEL; INFLAMMATION; ANTIOBESITY; PREVENTION; INHIBITION; APOPTOSIS;
D O I
10.3892/mmr.2021.12321
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Kaempferol, a flavonoid compound, has various biological functions, such as anti-inflammatory and antitumor activities. Acute liver failure (ALF) is a lethal clinical syndrome that occurs due to severe damage of the liver function. In the present study, the mechanisms underlying the therapeutic effects of kaempferol in ALF were evaluated. An ALF mouse model was established using D-galactosamine (D-GalN; 700 mg/kg)/lipopolysaccharide (LPS; 10 mu g/kg). A total of 2 h before the administration of D-GalN/LPS, mice were pretreated with different doses of kaempferol (2.5, 5, 10, 20 and 40 mg/kg), and 6 h after injection of D-GalN/LPS, mice were euthanized. The survival rate, liver function and levels of inflammatory cytokines were assessed. The results demonstrated that kaempferol pretreatment protected hepatocytes from ALF induced by D-GalN/LPS via regulation of the autophagy pathway, both in vivo and in vitro. Pretreatment with a high dose of kaempferol significantly decreased the survival rates and increased severe liver damage; however, pretreatment with a low dose of kaempferol had the opposite effect. Furthermore, pretreatment with a high dose of kaempferol enhanced the levels of proinflammatory cytokines [TNF-alpha, IL-6, IL-12p40, IL-1 beta, C-X-C motif chemokine ligand (CXCL)-2, CXCL-10] and markers of the MAPK signaling pathway [phosphorylated (p)-JNK, p-ERK, p-p38], whereas pretreatment with a low dose of kaempferol had the opposite effect. Pretreatment with a high dose of kaempferol decreased autophagy, whereas pretreatment with a low dose of kaempferol increased autophagy in vivo and in vitro. It was also shown that pretreatment with 3-methyadenine or autophagy related 7 small interfering RNA, to inhibit autophagy, partially abrogated the hepatoprotective effects of pretreatment with 5 mg/kg kaempferol in the ALF mouse model. These results demonstrate that the effects of different doses of kaempferol on D-GalN/LPS-induced ALF varies based on the dose, and that kaempferol exerted its effects via regulation of the autophagy pathway.
引用
收藏
页数:12
相关论文
共 29 条
  • [1] Kaempferol protects mice from D-GalN/LPS-induced acute liver failure by regulating the ER stress-Grp78-CHOP signaling pathway
    Wang, Huijuan
    Chen, Liyan
    Zhang, Xiangying
    Xu, Lin
    Xie, Bangxiang
    Shi, Hongbo
    Duan, Zhongping
    Zhang, Huanhu
    Ren, Feng
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 111 : 468 - 475
  • [2] Astragaloside IV Alleviates Acute Liver Failure Induced by D-GalN/LPS by Upregulating Autophagy and Reducing Inflammation
    Hong, Meng
    Lian, Wenwen
    Yang, Ying
    Chen, Zhi
    INFECTIOUS MICROBES & DISEASES, 2024, 6 (01): : 20 - 28
  • [3] Bone marrow mesenchymal stem cell-derived exosomes attenuate D-GalN/LPS-induced hepatocyte apoptosis by activating autophagy in vitro
    Zhao, Shuxian
    Liu, Yan
    Pu, Zenghui
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 13 : 2887 - 2897
  • [4] AMPK activation ameliorates D-GalN/LPS-induced acute liver failure by upregulating Foxo3A to induce autophagy
    Liu, Yan-Min
    Lv, Jun
    Zeng, Qing-Lei
    Shen, Shen
    Xing, Ji-Yuan
    Zhang, Ying-Ying
    Zhang, Zhi-Hao
    Yu, Zu-Jiang
    EXPERIMENTAL CELL RESEARCH, 2017, 358 (02) : 335 - 342
  • [5] Piceatannol attenuates D-GalN/LPS-induced hepatoxicity in mice: Involvement of ER stress, inflammation and oxidative stress
    Wen, Jingjing
    Lin, Hongfa
    Zhao, Mengshu
    Tao, Liang
    Yang, Yunxia
    Xu, Xi
    Jia, Aiqun
    Zhang, Jianfa
    Weng, Dan
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2018, 64 : 131 - 139
  • [6] Pretreatment of lipopolysaccharide (LPS) ameliorates D-GalN/LPS induced acute liver failure through TLR4 signaling pathway
    Zhang, Sainan
    Yang, Naibin
    Ni, Shunlan
    Li, Wenyuan
    Xu, Lanman
    Dong, Peihong
    Lu, Mingqin
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (10): : 6626 - 6634
  • [7] Prevention of D-GalN/LPS-induced ALI by 18β-glycyrrhetinic acid through PXR-mediated inhibition of autophagy degradation
    Wu, Shouyan
    Lu, Henglei
    Wang, Wenjie
    Song, Luyao
    Liu, Meng
    Cao, Yuhan
    Qi, Xinming
    Sun, Jianhua
    Gong, Likun
    CELL DEATH & DISEASE, 2021, 12 (05)
  • [8] Graveoline attenuates D-GalN/LPS-induced acute liver injury via inhibition of JAK1/STAT3 signaling pathway
    He, Jia
    Feng, Xu
    Liu, Yanyang
    Wang, Yuxin
    Ge, Chengyu
    Liu, Shao
    Jiang, Yueping
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 177
  • [9] Protective Effects of p-CA Against Acute Liver Damage Induced by LPS/D-GalN in Wistar Albino Rats
    Mehdi, Seerat
    Ahmad, Fiaz-ud-Din
    Lodhi, Arslan Hussain
    Khurshid, Umair
    Khalid, Ahmed Awais
    Sidiq, Sheikh Safeena
    Hussain, Liaqat
    Baig, Mirza Shaharyar
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2022, 16 : 3327 - 3342
  • [10] Oxidative stress promotes D-GalN/LPS-induced acute hepatotoxicity by increasing glycogen synthase kinase 3β activity
    Wei, Linlin
    Ren, Feng
    Zhang, Xiangying
    Wen, Tao
    Shi, Hongbo
    Zheng, Sujun
    Zhang, Jing
    Chen, Yu
    Han, Yuanping
    Duan, Zhongping
    INFLAMMATION RESEARCH, 2014, 63 (06) : 485 - 494